Physician profile
Colleen Helen Cotton
NPI 1669818589
$17,673.84
in general payments reported to CMS, 2019-2025
16 companies · $3,333 in 2025
The $3,333 reported for 2025 was more than what 81% of Pediatric Dermatology providers received nationally (typical 2025 total: $302).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,885 · 2021: $4,014 · 2022: $511 · 2023: $3,849 · 2024: $4,082 · 2025: $3,333.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,850 · Travel and Lodging: $3,469 · Food and Beverage: $1,839 · Education: $106.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,850.00 |
| Travel and Lodging | $3,469.13 |
| Food and Beverage | $1,838.61 |
| Education | $105.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pierre Fabre Pharmaceuticals, INC. | $7,881.92 | 2019-2024 | Hemangeol |
| Novartis Pharmaceuticals Corporation | $3,284.17 | 2022-2025 | |
| Leo Pharma INC. | $2,900.00 | 2023 | |
| Pfizer INC. | $2,171.00 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $476.66 | 2022-2025 | Dupixent |
| Ucb, INC. | $272.71 | 2022-2025 | Cimzia |
| Avita Medical Americas, LLC | $250.00 | 2023 | Recell |
| Sanofi-Aventis U.S. LLC | $99.00 | 2023 | |
| Genzyme Corporation | $83.98 | 2022-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $80.57 | 2023 | |
| Arcutis Biotherapeutics, INC. | $48.90 | 2025 | Zoryve |
| Incyte Corporation | $40.03 | 2025 | |
| Janssen Research & Development, LLC | $33.93 | 2022 | |
| Krystal Biotech INC | $26.59 | 2023 | Vyjuvek |
| Regeneron Pharmaceuticals, INC. | $24.38 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Colleen Cotton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.